876131-12-3

Basic information

• Product Name: 3-[4-(4-benzyloxycarbonylaminobutyl)phenoxy]-2-(tritylamino)propionic acid methyl ester
• Synonyms: 3-[4-(4-benzyloxycarbonylaminobutyl)phenoxy]-2-(tritylamino)propionic acid methyl ester
• CAS NO: 876131-12-3
• Molecular Weight: 642.795
• Mol File: 876131-12-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-[4-(4-benzyloxycarbonylaminobutyl)phenoxy]-2-(tritylamino)propionic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[4-(4-benzyloxycarbonylaminobutyl)phenoxy]-2-(tritylamino)propionic acid methyl ester(876131-12-3)
• EPA Substance Registry System: 3-[4-(4-benzyloxycarbonylaminobutyl)phenoxy]-2-(tritylamino)propionic acid methyl ester(876131-12-3)

Safety Data

• Hazardous Substances Data: 876131-12-3(Hazardous Substances Data)

Upstream product

• 587880-25-9 4-(4-hydroxyphenyl)butylcarbamic acid benzyl ester 
• 13515-76-9 methyl N-trityl-L-serinate 

Downstream Products

• 1011712-97-2 C₂₂H₂₈N₂O₅ 
• 1011712-98-3 C₂HF₃O₂*C₂₂H₂₈N₂O₅ 

Relevant articles and documents

METHODS OF ENHANCING MUCOSAL HYDRATION AND MUCOSAL CLEARANCE BY TREATMENT WITH SODIUM CHANNEL BLOCKERS AND OSMOLYTES

The present invention relates to methods and compositions for treating diseases ameliorated by increased mucociliary clearance and mucosal hydration by administering an effective amount of a sodium channel blocker as defined herein and an osmolyte to a su

Soluble amide & ester pyrazinoylguanidine sodium channel blockers

The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.